VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
AMN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
AMNAMN Healthcare Services, Inc.
$38.10$1.5B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
  1. Home
  2. Financial Ratios

  1. Home
  2. Stocks
  3. AMN
  4. Financial Ratios

AMN Healthcare Services, Inc. (AMN) Financial Ratios

Latest Ratios: P/E Ratio 14.0x · EV/EBITDA 6.6x · ROE -14.2%. (2000–2025 historical series)

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly

AMN Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Market Cap$1.5B$607M$913M$2.9B$4.6B$5.9B$3.3B$3.0B$2.8B$2.4B$1.9B
Enterprise Value$2.2B$1.4B$2.0B$4.3B$5.4B$6.6B$4.2B$3.6B$3.2B$2.7B$2.2B
P/E Ratio →14.04——13.9710.3917.9646.1125.9619.4718.3817.88
P/S Ratio0.420.220.310.780.881.481.361.331.291.221.00
P/B Ratio2.290.951.293.544.425.063.974.034.324.334.22
P/FCF4.522.603.8110.978.0523.3514.9515.7414.4727.4417.24
P/OCF5.482.252.857.927.0619.2512.6713.1912.1521.1214.37

P/E links to full P/E history page with 30-year chart

AMN EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
EV / Revenue—0.500.671.131.031.651.751.621.491.381.18
EV / EBITDA6.587.2528.148.546.9011.2817.1715.3113.0511.1910.15
EV / EBIT67.75——12.608.3613.7328.0120.3815.7012.8911.72
EV / FCF—5.898.3515.889.4426.0819.2019.1316.7130.8720.44

AMN Profitability

Margins and return-on-capital ratios measuring operating efficiency

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Gross Margin28.3%28.3%30.8%33.0%32.7%32.9%33.1%33.5%32.6%32.4%32.6%
Operating Margin1.2%1.2%-3.4%8.9%12.3%12.0%6.2%8.0%9.5%10.7%10.1%
Net Profit Margin-3.5%-3.5%-4.9%5.6%8.5%8.2%3.0%5.1%6.6%6.7%5.6%

Return on Capital

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
ROE-14.2%-14.2%-19.1%22.5%40.3%33.0%9.1%16.6%23.6%26.2%26.6%
ROA-4.2%-4.2%-5.5%7.2%14.8%11.9%3.3%6.7%10.3%10.9%10.2%
ROIC1.6%1.6%-3.9%12.7%26.3%19.9%7.2%10.9%15.7%19.1%21.2%
ROCE2.0%2.0%-5.0%15.7%30.9%23.4%8.6%12.9%18.7%22.4%24.9%

AMN Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Debt / Equity1.251.251.551.620.820.751.170.980.690.570.81
Debt / EBITDA4.234.2315.442.701.101.493.923.071.811.311.64
Net Debt / Equity—1.201.541.580.760.591.130.870.670.540.78
Net Debt / EBITDA4.054.0515.292.641.021.183.802.721.751.251.59
Debt / FCF—3.294.544.911.392.734.253.392.243.433.21
Interest Coverage-1.22-1.22-1.476.2516.0214.032.596.2212.5610.8012.39

AMN Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Current Ratio0.940.941.091.281.271.391.261.481.571.791.64
Quick Ratio0.940.941.091.281.271.391.171.481.441.571.51
Cash Ratio0.060.060.020.050.080.190.070.220.050.060.04
Asset Turnover—1.301.241.301.821.271.021.151.431.591.60
Inventory Turnover——————41.24—36.4123.2137.22
Days Sales Outstanding—58.7063.6171.9166.3694.2568.6370.8671.2274.7875.13

AMN Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Dividend Yield———————————
Payout Ratio———————————

Total Shareholder Return Metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Earnings Yield7.1%——7.2%9.6%5.6%2.2%3.9%5.1%5.4%5.6%
FCF Yield22.1%38.5%26.2%9.1%12.4%4.3%6.7%6.4%6.9%3.6%5.8%
Buyback Yield0.1%0.3%0.0%14.4%12.5%0.0%0.2%0.6%2.4%0.8%0.7%
Total Shareholder Yield0.1%0.3%0.0%14.4%12.5%0.0%0.2%0.6%2.4%0.8%0.7%
Shares Outstanding—$39M$38M$39M$45M$48M$48M$48M$49M$49M$49M

Key Metrics

Growth RegimeMixed
ProfitabilityWeak
Balance SheetMixed
Cash FlowMixed
Top Statement Risk

Hospital labor demand volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Low Multiples Price in Cyclical Risk

Based on reported figures, AMN trades at 13.33x trailing P/E and 6.36x EV/EBITDA, a discount to CHE's 16.17x EV/EBITDA and HCSG's 11.88x, suggesting the market prices AMN as a cyclical staffing business rather than a healthcare technology platform.

The forward P/E of 11.01 implies modest expected earnings growth, yet this must be weighed against trailing negative net margin of -3.50% and negative ROE of -14.2%, which make the trailing P/E less meaningful as a clean earnings anchor. The P/FCF of 4.29 looks inexpensive, but it is distorted by the negative free cash flow in recent quarters and should be read as a function of working capital timing rather than durable cash generation. Investors should monitor whether the valuation discount narrows if the Technology and Workforce segment grows as a share of revenue.

Margin Recovery Masked by Overhead Drag

As reported in financial statements, AMN's gross margin rose to 31.9% in 2026Q3 from 26.1% in 2025Q4, yet operating margin of 7.0% and trailing net margin of -3.5% indicate that SG&A absorbs most of the gross profit improvement.

The gap between a 28.35% gross margin and a 1.21% operating margin implies a high fixed overhead burden relative to a variable-cost clinician model, which limits operating leverage on incremental revenue. Quarterly net margin of 4.7% in 2026Q3 contrasts sharply with the trailing negative figure, suggesting earnings remain volatile and sensitive to impairment or one-time items. Investors should treat the recent quarter as evidence of recovery to be confirmed by sustained operating margin expansion.

Deleveraging Improves Coverage Profile

According to recent quarterly figures, AMN's debt-to-equity fell from 1.57 in 2025Q2 to 0.96 in 2026Q3 while interest coverage recovered to 6.89x, indicating debt service has become considerably more comfortable than during the prior trough.

The reduction in debt from roughly $956M to $743M appears to have driven most of the leverage improvement, rather than equity expansion alone. Debt-to-EBITDA of 9.03x remains elevated relative to typical staffing peers, so the coverage improvement depends heavily on continued EBITDA recovery. Refinancing exposure and the sensitivity of earnings to a renewed demand downturn warrant further investigation.

Cash Rebuild Offsets Thin Current Cushion

Based on reported figures, AMN's cash rose to $256.0M in 2026Q3 from $34.0M at 2025Q4, lifting the current ratio to 1.21, a buffer that was previously very limited and remains modest relative to total liabilities.

The current ratio equal to the quick ratio at 1.21 indicates that inventory is not a meaningful component of liquidity for this service-based model, so liquidity rests almost entirely on cash and receivables. Receivables-dependent liquidity is exposed if hospital customers delay payments under budget pressure, a risk reflected in the DSO of 54 days. Under a severe stress scenario, the position would depend on sustained collections, and the recent history of sharp working capital swings suggests this cushion may be less durable than the headline ratio implies.

Misapplied P/E Obscures Acquisition Amortization

Based on reported figures, the trailing P/E of 13.33x is most commonly misapplied to AMN, because heavy acquisition-related amortization and impairment charges distort GAAP earnings and make the multiple look cheaper or more expensive than the underlying business warrants.

Investors often use GAAP P/E as a shorthand for earning power, but AMN's earnings are depressed by amortization from acquisitions such as B.E. Smith and Stratus, which creates a wide gap between GAAP and adjusted results. A more informative approach would be EV/EBITDA adjusted for stock-based compensation, combined with free cash flow yield normalized for working capital timing. Investors should monitor whether the gap between GAAP and adjusted earnings narrows as acquisition intangibles amortize.

Download Financial Ratios Data

Includes 30+ ratios · 26 years · Updated daily

Consensus & Technical Research Suite
Open AMN Terminal

AMN Chart Terminal

WASM

Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.

Launch Terminal

Live Breakouts Feed

LIVE

High-probability breakout stocks crossing their pivot across 5 pattern engines.

Explore Setups

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

AMN — Frequently Asked Questions

Quick answers to the most common questions about buying AMN stock.

What is AMN Healthcare Services, Inc.'s P/E ratio?

AMN Healthcare Services, Inc.'s current P/E ratio is 14.0x. The historical average is 35.9x. This places it at the 11th percentile of its historical range.

What is AMN Healthcare Services, Inc.'s EV/EBITDA?

AMN Healthcare Services, Inc.'s current EV/EBITDA is 6.6x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 17.7x.

What is AMN Healthcare Services, Inc.'s ROE?

AMN Healthcare Services, Inc.'s return on equity (ROE) is -14.2%. The historical average is 8.6%.

Is AMN stock overvalued?

Based on historical data, AMN Healthcare Services, Inc. is trading at a P/E of 14.0x. This is at the 11th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.

What are AMN Healthcare Services, Inc.'s profit margins?

AMN Healthcare Services, Inc. has 28.3% gross margin and 1.2% operating margin.

How much debt does AMN Healthcare Services, Inc. have?

AMN Healthcare Services, Inc.'s Debt/EBITDA ratio is 4.2x, indicating high leverage. A ratio above 4x may signal elevated financial risk.